`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`Under Armour Inc.
`Petitioner
`
`v.
`
`adidas AG,
`Patent Owner
`
`
`
`
`Case No. IPR2015-01532
`
`Patent No. 8,652,009
`
`PATENT OWNER ADIDAS AG’S OBJECTIONS TO ADMISSIBILITY OF
`EVIDENCE SERVED WITH PETITIONER UNDER ARMOUR INC.’S
`PETITION FOR INTER PARTES REVIEW
`
`Pursuant to 37 C.F.R. § 42.64(b), Patent Owner adidas AG objects as
`
`follows to the admissibility of evidence served with Petitioner Under Armour
`
`Inc.’s Petition for Inter Partes Review of U.S. Patent No. 8,652,009.
`
`
`
`
`
`1
`
`
`
`U.S. Pat. No. 8,652,009
`IPR2015-01532
`Patent Owner’s Objections to
`Admissibility of Evidence
`
`
`Evidence
`
`Objections
`
`Exhibit 1002
`
`FRE 402: the exhibit is not relevant to any ground upon which
`
`trial was instituted.
`
`FRE 403: the exhibit’s probative value to any ground upon
`
`which trial was instituted is substantially outweighed by the
`
`danger of unfair prejudice, confusing the issues, undue delay,
`
`wasting time, or needlessly presenting cumulative evidence.
`
`Exhibit 1003
`
`FRE 402: portions of the exhibit, including but not limited to
`
`Paragraphs 46-49 and 80-83, are not relevant to any ground upon
`
`which trial was instituted.
`
`FRE 403: the exhibit’s probative value to any ground upon
`
`which trial was instituted is substantially outweighed by the
`
`danger of unfair prejudice, confusing the issues, undue delay,
`
`wasting time, or needlessly presenting cumulative evidence.
`
`FRE 602: Paragraphs 9-11, 12-15, 16-20, 21-24, 25-26, and 27-
`
`85 of the exhibit includes assertions for which evidence has not
`
`been introduced sufficient to show that the witness has personal
`
`knowledge of the matters asserted.
`
`2
`
`
`
`U.S. Pat. No. 8,652,009
`IPR2015-01532
`Patent Owner’s Objections to
`Admissibility of Evidence
`
`
`Evidence
`
`Objections
`
`FRE 701/702/703: Paragraphs 9-11, 12-15, 16-20, 21-24, 25-26,
`
`and 27-85 of the exhibit include opinions that are not admissible
`
`under FRE 701, 702, or 703, or Daubert v. Merrell Dow Pharms.,
`
`Inc., 509 U.S. 579 (1993).
`
`FRE 801/802: Paragraphs 9-11, 12-15, 16-20, 21-24, 25-26, and
`
`27-85 of the exhibit includes statements that are inadmissible
`
`hearsay if offered to prove the truth of any matter allegedly
`
`asserted therein.
`
`FRE 805: the exhibit contains improper hearsay within hearsay.
`
`FRE 1006: the exhibit provides an improper summary of the
`
`evidence.
`
`37 C.F.R. § 42.65: the exhibit includes expert testimony that
`
`does not disclose the underlying facts or data and improper
`
`discussion of patent law.
`
`Exhibit 1007
`
`FRE 402: the exhibit is not relevant to any ground upon which
`
`trial was instituted.
`
`FRE 403: the exhibit’s probative value to any ground upon
`
`3
`
`
`
`U.S. Pat. No. 8,652,009
`IPR2015-01532
`Patent Owner’s Objections to
`Admissibility of Evidence
`
`
`Evidence
`
`Objections
`
`which trial was instituted is substantially outweighed by the
`
`danger of unfair prejudice, confusing the issues, undue delay,
`
`wasting time, or needlessly presenting cumulative evidence.
`
`By: /s/ Mitchell G. Stockwell_________
`
`Mitchell G. Stockwell
`Reg. No. 39,389
`Lead Counsel for Patent Owner
`
`
`
`Dated: January 28, 2016
`
`
`
`4
`
`
`
`U.S. Pat. No. 8,652,009
`IPR2015-01532
`Patent Owner’s Objections to
`Admissibility of Evidence
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of PATENT OWNER
`
`ADIDAS AG’S OBJECTIONS TO ADMISSIBILITY OF EVIDENCE
`
`SERVED WITH PETITIONER UNDER ARMOUR INC.’S PETITION FOR
`
`INTER PARTES REVIEW was served via email on the date below, upon the
`
`following:
`
`Brian E. Ferguson
`Weil, Gotshal & Manges LLP
`1300 Eye Street NW, Suite 900
`Washington, DC 20005
`Phone: 202-682-7516
`brian.ferguson@weil.com
`
`
`
`Dated: January 28, 2016
`
`
`
`Anish R. Desai
`Weil Gotshal & Manges LLP
`1300 Eye Street NW, Suite 900
`Washington, DC 20005
`Phone: 202-682-7103
`anish.desai@weil.com
`
`By: /s/ Mitchell G. Stockwell_________
`
`Mitchell G. Stockwell
`Reg. No. 39,389
`Lead Counsel for Patent Owner
`
`5



